New York A09010 requires practitioners to discuss risks with patients before prescribing Schedule II controlled substances or opioid analgesics, and.
New York A09010 mandates that healthcare practitioners discuss specific risks with patients before prescribing Schedule II controlled substances or opioid analgesics. These discussions must cover the risks of addiction, overdose, and the dangers of combining opioids with alcohol or other central nervous system depressants. The bill also requires practitioners to inform patients about alternative treatments. Exemptions apply for cancer treatment, hospice care, post-surgery treatment, and medical emergencies.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.